Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-26 · accession 0001415889-23-003569 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-28 | 2023-02-26 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +11.8K | 10.1K | New | $0 |
| DM | 2023-02-28 | 2023-02-26 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +32.7K | 28.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-02-26 | A | A | 1,688 | $0.00 | 11,819 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-02-26 | A | A | 10,131 | $0.00 | 10,131 | D | — | — | |
| 3 | Derivative | Share Option (Right to Buy) | 2023-02-26 | A | A | 4,666 | $0.00 | 4,666 | D | $9.87 · — to 2033-02-25 | 4,666 Ordinary Shares | (F2) This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders. |
| 4 | Derivative | Share Option (Right to Buy) | 2023-02-26 | A | A | 28,000 | $0.00 | 28,000 | D | $9.87 · — to 2033-02-25 | 28,000 Ordinary Shares | (F1) The option vests monthly over 24 months of service from the date of grant. |